These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Restless legs syndrome. Definition, cause and treatment]. Jennum PJ Ugeskr Laeger; 2007 Sep; 169(38):3187-90. PubMed ID: 17910827 [TBL] [Abstract][Full Text] [Related]
25. Suspected Agomelatine-induced restless legs syndrome: a case report. Abdul Karim M; Al-Baz N; Ouanes S; Alabdulla M; Haddad PM BMC Psychiatry; 2021 Apr; 21(1):180. PubMed ID: 33827492 [TBL] [Abstract][Full Text] [Related]
26. Current treatment options for restless legs syndrome. Wetter TC; Winkelmann J; Eisensehr I Expert Opin Pharmacother; 2003 Oct; 4(10):1727-38. PubMed ID: 14521483 [TBL] [Abstract][Full Text] [Related]
27. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome. Bogan RK Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821 [TBL] [Abstract][Full Text] [Related]
29. Restless legs syndrome related to hemorrhage of a thoracic spinal cord cavernoma. Hamdaoui M; Ruppert E; Comtet H; Kilic-Huck U; Wolff V; Bataillard M; Bourgin P J Spinal Cord Med; 2018 Mar; 41(2):245-247. PubMed ID: 28899286 [TBL] [Abstract][Full Text] [Related]
30. Dopamine agonists for the treatment of restless legs syndrome. Fulda S; Wetter TC Expert Opin Pharmacother; 2005 Dec; 6(15):2655-66. PubMed ID: 16316304 [TBL] [Abstract][Full Text] [Related]
31. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations. Geyer J; Bogan R Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004 [TBL] [Abstract][Full Text] [Related]
32. Clinical management of restless legs syndrome in end-stage renal disease patients. Sahli ZT; Jo J; Mousa SA; Tarazi FI CNS Spectr; 2017 Feb; 22(1):14-21. PubMed ID: 27702420 [TBL] [Abstract][Full Text] [Related]
34. THE RESTLESS LEGS SYNDROME (REVIEW). Japaridze G; Kasradze S; Maisuradze L; Popp R; Wetter T Georgian Med News; 2018 Dec; (285):74-81. PubMed ID: 30702074 [TBL] [Abstract][Full Text] [Related]
35. [Restless legs syndrome. Therapy according to plan]. Eckardt KM; Trenkwalder C MMW Fortschr Med; 2001 May; 143 Suppl 2():13-7. PubMed ID: 11434251 [TBL] [Abstract][Full Text] [Related]
37. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome. Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491 [TBL] [Abstract][Full Text] [Related]
38. Treatment options for restless legs syndrome. Ferini-Strambi L Expert Opin Pharmacother; 2009 Mar; 10(4):545-54. PubMed ID: 19284359 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ; Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323 [TBL] [Abstract][Full Text] [Related]
40. Empirical evaluation of the accuracy of diagnostic criteria for Restless Legs Syndrome. Benes H; von Eye A; Kohnen R Sleep Med; 2009 May; 10(5):524-30. PubMed ID: 18996741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]